Global Hemostats Market - 2024-2031

Global Hemostats Market - 2024-2031


Global Hemostats Market reached US$ XX million in 2023 and is expected to reach US$ XX million by 2031, growing at a CAGR of XX% during the forecast period 2024-2031

A hemostat is a surgical tool to control bleeding by clamping exposed blood vessels shut. It is similar to pliers and scissors and is part of a group of pivoting instruments that determine its function. The hemostat's locking mechanism, consisting of interlocking teeth, allows the user to adjust the clamping force of the pliers. Hemostats are often used in the first stages of surgery to line incisions on blood vessels awaiting ligation.

Market Dynamics: Drivers & Restraints

Rise in the number of surgical procedures

The hemostats market growth is driven by the rise in chronic diseases like spinal problems, cardiovascular diseases, cancer, accidents, and trauma. Hemostats play a crucial role in blood control during surgical procedures, as they are used in 60-70% of transfused red blood cells. In 2020, the U.S. had 1,806,590 new cancer cases.

The demand for hemostat products in surgical procedures is increasing due to the minimal risk of blood loss, their lower infection risk, and their cost-effectiveness. The increase in surgeries is expected to boost the revenue of the hemostats market, as surgeons increasingly choose these products for their minimal risk of blood loss.

Furthermore, the global hemostats market are also driven by various other factors like a rise in the advancements of devices, a rise in healthcare infrastructure and others helping the market to grow during the forecast period.

Limited access in developing regions

Thermostat agents and devices are vital in modern healthcare, but their availability is limited in underserved and developing regions due to inadequate healthcare infrastructure. This affects the availability of surgical services and necessary tools, including hemostatic products. In these areas, limited facilities and resources make it difficult for patients to access necessary surgical care.

For more details on this report – Request for Sample

Segment Analysis

The global hemostats market is segmented based on product type, application, end-user and region.

The halstead mosquito hemostatic forceps from the product type segment accounted for approximately 39.3% of the hemostats market share

The halstead mosquito hemostatic forceps from the product type segment accounted for approximately 39.3%. Halsted (or Halstead) Mosquito Forceps, also called mosquito hemostatic forceps or simply hemostats, are surgical instruments designed for clamping blood vessels or other small tissues to control bleeding during surgery or to provide a secure grip. They are so named because they resemble the slender legs of a mosquito. Life science researchers like these fine hemostats because of their secure grip and the ability to manipulate them in confined spaces.

Geographical Analysis

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to factors like the novel product launches by key players, advancements in the forceps, rise in the prevalence of chronic diseases, rise in the number of surgical procedures and others help the region to have highest market share during the forecast period.

For instance, according to the Organization for Economic Co-Operation and Development in 2021, they were 3,83,717 surgical procedures were performed in Canada. Hence the demand for the surgical hemostat’s forceps increases simultaneously which helps the region and market to grow during the forecast period.

Covid 19 Impact Analysis

The impact of COVID-19 on hemostats has been significant where hospitals and healthcare facilities have faced surges in patient volumes due to COVID-19. This increased demand for medical equipment, including hemostats and forceps, especially in settings such as intensive care units (ICUs) and emergency departments where these instruments are commonly used.

Market Segmentation

By Product type
• Halstead mosquito hemostatic forceps
• Helly and Crile hemostatic forceps
• Rochester-carmalt hemostatic forceps
• Others

By Application
• Cardiovascular surgery
• General surgery
• Gynecological surgery
• Reconstructive surgery
• Neurological surgery
• Orthopedic surgery
• Others

By End User
• Hospitals
• Ambulatory Surgical Centers
• Others

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Spain
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include Integralife Lifesciences, Artivion, Medesy, World Precision Instruments, Agnthos, GerMed USA, Burtons Veterinary, Prodent USA, Thermo Fisher Scientific Inc, Bausch & Lomb Incorporated among others.

Why Purchase the Report??
• To visualize the global hemostats market segmentation based on product type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analysing trends and co-development.
• Excel data sheet with numerous data points of the hemostats market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global hemostats market report would provide approximately 64 tables, 61 figures and 186 pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in the number of surgical procedures
4.1.1.2. Rise in the advancements of devices
4.1.2. Restraints
4.1.2.1. Limited access in developing regions
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. PESTLE Analysis
5.7. SWOT Analysis
5.8. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Halstead mosquito hemostatic forceps *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Helly and Crile hemostatic forceps
7.4. Rochester-carmalt hemostatic forceps
7.5. Others
8. By Application
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Cardiovascular surgery*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. General surgery
8.4. Gynecological surgery
8.5. Reconstructive surgery
8.6. Neurological surgery
8.7. Orthopedic surgery
8.8. Other surgeries
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgery Centers
9.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. South Korea
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Integralife Lifesciences*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Artivion
12.3. Medesy
12.4. World Precision Instruments
12.5. Agnthos
12.6. GerMed USA
12.7. Burtons Veterinary
12.8. Prodent USA
12.9. Thermo Fisher Scientific Inc.
12.10. Bausch & Lomb Incorporated
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings